Chronic Overmedication: The Polypharmacy Waste and Safety Problem

Polypharmacy is a cost and safety problem that is solvable. The right technology platform can reduce it by identifying risky regimens, route specific “stop/switch/consolidate” opportunities to clinicians, and track whether changes stick through refill and adherence patterns. The post Chronic Overmedication: The Polypharmacy Waste and Safety Problem appeared first on MedCity News.

Read More

Valuing Early-Stage Life Sciences Companies: The Why, the How, and the Impact

Valuing early-stage life sciences companies can be complex. Because product development can take several years and be capital intensive, obtaining an accurate valuation is essential to align management’s, the shareholders’, and current and potential investors’ understanding of estimated value. The post Valuing Early-Stage Life Sciences Companies: The Why, the How, and the Impact appeared first…

Read More